La imagen puede variar dependiendo del país en el que se comercialice.
Laboratorio fabricante
Laboratorios Ovejero, S.A.
Medicamento sujeto a prescripción veterinaria
MYOGALAX
Vaccine against contagious agalactia, in an injectable suspension
Composición
Each dose (2 ml) contains:
Active substance:
Inactivated Mycoplasma agalactiae
Adjuvant:
Aluminium hydroxide and potassium aluminium
Preservative:
Active substance:
Inactivated Mycoplasma agalactiae
strain Ag 8 ≥ 0.93 ELISA U.*
*ELISA U.: Average antibody titre against Mycoplasma agalactiae in vaccinated lambs..
Adjuvant:
Aluminium hydroxide and potassium aluminium
sulphate dodecahydrate (Al3+) ≤5,5 mg
Preservative:
Phenol 0,10 – 0,12 mg/ml
Indicaciones
For active immunisation of sheep and goats against contagious agalactia caused by Mycoplasma agalactiae to prevent infection and reduce clinical signs and/or lesions of the disease.
Vía de administración
Subcutaneous.
Posología
Dose: 2ml
Pauta de vacunación
- Primary vaccination
- 2 doses: 15 days apart.
- For animals from 1 month of age.
- 2 doses: 15 days apart.
- Revaccination
- 1 dose.
- Sheep and goats: Every 6 months or 1 month before parturition. Revaccinate in all pregnancies.
- Breeding males: Every 6 months.
- 1 dose.
Tiempo de espera
Zero days.
